Medicine by Design (MbD) is the result of an unprecedented $114 million grant from the Canada First Research Excellence Fund, the single largest research award in University of Toronto’s history. Bringing together basic scientists, clinicians, surgeons, and students, MbD aims to bring regenerative medicine and cell therapy from science fiction to science reality.
Computer scientist, Medicine by Design, University of Toronto
“Medicine by Design is kind of like a science fiction concept. We want to try and fix injured tissues using science of stem cells.”
Heart Pathologist, University Health Network, Medicine by Design, University of Toronto
“The goal of our Medicine by Design program is to tackle some of the specific hurdles we see to making [regenerative medicine] into a viable therapy.”
Biomedical Engineering, Medicine by Design, University of Toronto
“Medicine by Design is really exciting because it’s really allowing us to try new collaborations in areas that were really unimaginable and really push the boundary.”
Kidney Doctor, St. Michael’s Hospital, Medicine by Design, University of Toronto
“What Medicine by Design does is bring together a large cohort of principal investigators and get them focused together as a team to make a difference.”
Neuroscientist, Hospital for Sick Children, Medicine by Design, University of Toronto
“We live in a time when something as complex as the brain, you could actually imagine deciphering it.”
President and CEO, Centre for Commercialization of Regenerative Medicine
“Medicine by Design represents the leading edge of cell and gene therapy.”
See how Medicine by Design researchers are collaborating the heal the injured brain and heart.